| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.48▼ | 4.48▲ | 4.46▲ | 4.30▲ | 4.14▲ |
| MA10 | 4.48▼ | 4.46▲ | 4.43▲ | 4.20▲ | 4.30▲ |
| MA20 | 4.48▼ | 4.43▲ | 4.37▲ | 4.12▲ | 4.39▲ |
| MA50 | 4.46▲ | 4.32▲ | 4.22▲ | 4.40▲ | 3.87▲ |
| MA100 | 4.44▲ | 4.19▲ | 4.09▲ | 4.42▲ | 3.67▲ |
| MA200 | 4.37▲ | 4.09▲ | 4.17▲ | 3.99▲ | 3.05▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.001▼ | 0.005▲ | 0.066▲ | -0.058▼ |
| RSI | 50.643▲ | 62.671▲ | 69.740▲ | 58.496▲ | 55.788▲ |
| STOCH | 42.857 | 78.085 | 77.852 | 84.617▲ | 37.474 |
| WILL %R | -71.429 | -18.519▲ | -8.197▲ | -2.825▲ | -37.580 |
| CCI | -72.165 | 77.127 | 98.383 | 159.575▲ | 6.165 |
|
Monday, January 12, 2026 09:00 AM
Arbutus Biopharma (ABUS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
|
|
Wednesday, August 06, 2025 11:48 AM
Arbutus Biopharma is a clinical-stage biotechnology company developing therapies targeting chronic hepatitis B virus (cHBV) and leveraging lipid nanoparticle (LNP) delivery technology. Its leading ...
|
|
Wednesday, September 25, 2024 06:40 AM
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Arbutus Biopharma (ABUS) one of those stocks right now? A ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/02/26 | 4.43 | 4.505 | 4.40 | 4.48 | 865,041 |
| 23/02/26 | 4.20 | 4.42 | 4.19 | 4.39 | 0 |
| 20/02/26 | 4.20 | 4.36 | 4.14 | 4.27 | 1,330,859 |
| 19/02/26 | 4.13 | 4.25 | 4.09 | 4.24 | 1,982,947 |
| 18/02/26 | 4.25 | 4.30 | 4.065 | 4.13 | 1,645,813 |
| 17/02/26 | 3.99 | 4.34 | 3.93 | 4.17 | 3,246,911 |
| 13/02/26 | 4.03 | 4.12 | 3.935 | 3.98 | 1,041,107 |
| 12/02/26 | 4.18 | 4.25 | 3.85 | 4.01 | 2,033,485 |
| 11/02/26 | 4.18 | 4.25 | 4.025 | 4.16 | 1,369,208 |
| 10/02/26 | 4.05 | 4.26 | 3.99 | 4.16 | 3,180,231 |
|
|
||||
|
|
||||
|
|